Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAXIMIN vs RILUZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAXIMIN vs RILUZOLE: Safety Overview

Metric RIFAXIMIN RILUZOLE
Total FAERS Reports 13,861 1,437
Deaths Reported 5,009 342
Death Rate 36.1% 23.8%
Hospitalizations 4,847 264
Average Patient Age 63.2 yrs 63.5 yrs
% Female Patients 54.9% 47.5%
FDA Approval Date Mar 24, 2010 Aug 22, 2024
Manufacturer Salix Pharmaceuticals, Inc. EDW PHARMA
Route ORAL ORAL
Marketing Status Prescription Discontinued